<DOC>
	<DOC>NCT01237925</DOC>
	<brief_summary>Topical antihistamines can be used to promote relief of sunburn related symptoms (erythema, itch and burning sensations). Dexchlorpheniramine maleate 1% cream is a topical antihistamine formulation approved by ANVISA in Brazil for the relief of skin irritation and pruritus, including the ones caused by sunburn. The aim of the present study is to demonstrate non-inferiority of a new pharmacological preparation of dexchlorpheniramine maleate (1% gel) with the standard preparation (1% cream) for the relief of sunburn related symptoms and to demonstrate the safety of both preparations.</brief_summary>
	<brief_title>Non-inferiority Clinical Trial of Dexchlorpheniramine (Cream Versus Gel) in the Relief of Sunburn Related Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Sunburn</mesh_term>
	<mesh_term>Dexchlorpheniramine</mesh_term>
	<mesh_term>Chlorpheniramine</mesh_term>
	<criteria>Signs of solar erythema of mild to moderate intensity resulting from voluntary exposure to sun within the last 72 hours Compliance of the subject to the treatment protocol Agreement with the terms of the informed consent by the participants or their legal guardians when younger than 18 years old Pregnancy or risk of pregnancy Lactation Signs of severe sunburn (vesicles, bullae or ulceration) Use of topical or systemic antiinflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study History of atopy or allergic diseases History of allergy to any component of the formulations Other conditions considered by the investigator as reasonable for noneligibility</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Sunburn</keyword>
	<keyword>Dexchlorpheniramine</keyword>
	<keyword>Gel</keyword>
	<keyword>Cream</keyword>
</DOC>